Iran’s Health Minister Mohammadreza Zafarghandi announced that his ministry will strive to prevent price increases for essential medicines covered by insurance, while acknowledging that imported drugs outside the insurance list could be affected by currency fluctuations. The remarks came on the sidelines of the opening ceremony of the 15th Sports Olympiad for female students from the country’s medical universities.
Iran essential medicine prices
Speaking to reporters, Mr Zafarghandi emphasised the government’s main objective is to maintain price stability for drugs that appear on the national insurance list. He said the policy aims to shield patients from sudden cost rises and to ensure access to critical treatments across the healthcare system.
“Our priority is to keep insured, essential medicines at stable prices,” he said. “Medicines that are imported and not covered by insurance may be subject to exchange rate pressures, but our principal policy remains the protection of patients’ access to necessary drugs.”
Iran has faced persistent economic pressures in recent years, and the cost of imported medical supplies has been a recurring concern. By committing to maintain the prices of medicines within the insurance framework, the health ministry seeks to reduce the burden on households and the public health system. Officials did not provide specific measures in the remarks, but the statement signals continued government attention to pharmaceutical affordability.
Mr Zafarghandi made his remarks while attending a university sporting event designed to promote physical activity among female students in medical fields. He underlined the importance of creating a vibrant campus environment where students can balance rigorous academic work with cultural and sporting activities.
Organisers said the Olympiad marks a return to nationwide university sports competitions after a six year interruption. The health ministry plans to work with the Ministry of Sport and Youth to make use of existing facilities and expand opportunities for students across the country.
“We want medical students to pursue their studies while also taking part in cultural and athletic programmes,” Mr Zafarghandi said. “Reviving these events supports both education and student wellbeing.”
Observers noted the two strands of the minister’s message. On one hand, the pledge to limit price rises for insured medicines is a pragmatic response to public concern about healthcare costs. On the other, investment in student sport reflects broader social policy objectives to foster healthier, more active communities.
Healthcare analysts said managing medicine prices will require coordination among the health ministry, insurance funds and the pharmaceutical sector. Addressing the vulnerabilities of imported, non-insured drugs will likely involve negotiating supply contracts, exploring local production where feasible, and monitoring currency impacts on procurement.
For patients who rely on medicines covered by insurance, the minister’s statement offers a measure of reassurance. For others whose treatments fall outside the insurance list, the ministry’s warning about exchange rate exposure serves as a reminder of the ongoing economic challenges in ensuring nationwide access to all categories of medicines.
As Iran balances fiscal pressures and public health priorities, policymakers will be watched for concrete steps to translate the promise of price stability into tangible measures that protect patients and support the health system.
Key Takeaways:
- Health Minister Mohammadreza Zafarghandi says the government will aim to keep prices of insured essential medicines steady to protect patients.
- Imported medicines outside the insurance list may face price pressure from exchange rate fluctuations, the minister warned.
- Officials plan to revive nationwide university sports after a six year pause, enhancing student well being alongside studies.
- Policy focus: Iran essential medicine prices stability to ensure affordability for patients.
